| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.16 | 2e-05 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | -0.16 | 4e-05 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.24 | 4e-05 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.15 | 4e-05 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.16 | 4e-05 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.17 | 5e-05 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.21 | 5e-05 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.19 | 8e-05 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.18 | 8e-05 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.55 | 8e-05 |